Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Apple: No Perfect Quarter

The rare earnings and revenue miss was telegraphed, but AAPL shares are dropping anyway. Still, there's some good news, and the price just got more attractive.

Earnings Coaster Dips for Apple — Tuesday’s IP Market Recap

Earnings news dominated Tuesday's trading, but some of the biggest moves came after the bell, when investors hacked away at AAPL and NFLX.

Gold, Silver Make Marginal Moves Tuesday

Gold and silver prices slid slightly on Tuesday. Miners were more of a mixed bag, though Agnico-Eagle and Eldorado Gold were sparked to life.

Netflix Takes Hit After Earnings

Netflix beat earnings estimates in the second quarter, but shares still couldn't catch a break.

Lockheed Martin Tops Forecasts, Raises Outlook

Lockheed Martin shook off the prospect of looming cuts in U.S. defense spending to raise its outlook for the year as it topped second-quarter profit estimates.

Lexmark Misses Q2 Estimates, Warns on Q3, Shares Dive

Lexmark announced second-quarter net income and revenue that fell short of expectations and warned that revenue would decline during the current quarter.

China’s Energy-Buying Binge Is Just Starting

CNOOC's $15 billion grab of Canada's Nexen means more deals are coming, particularly in Canada. Here are some possibilities for the next to go.

Spain Is an Early Drain: Monday’s IP Market Recap

Stocks managed to find their footing after a very tough start due to concerns over Spain's ability to avoid default problems.

Gold, Silver Slide; Eldorado Gold Hammered

Gold and silver prices drop Monday, and miners also head lower as analysts get to Eldorado Gold and Silver Wheaton.

Novartis Wins Approval for Breast Cancer Drug

The FDA has granted approval for Novartis' drug Afinitor to be used as a treatment for breast cancer after it showed promise in clinical trials.

Nokia Brushes Off Moody’s Downgrade

Nokia officials said that Moody's recent two-notch downgrade of its credit rating would have a "limited" impact on the company.

Why McDonald’s Is Worth Sticking With

Multiple headwinds -- from currency exchange and rising prices to the general global slowdown -- are clearly hurting, but it will be fine in the long run.

After Chipotle, Watch These 3 Momentum Stocks for Danger

It might take a while, but these three big-time growth stocks may become big-time losers. Here's why they show signs of going from red-hot to stone-cold.

Tech Is Still The Toast of the Town

Tech stocks continue to do well despite only mediocre earnings, while gold mining stocks are lagging the markets.

Gold, Silver Finish Friday With Slight Gains

Gold and silver futures climbed slightly Friday, while mining stocks were mostly mixed.

SunTrust Won’t Raise Dividend Until 2013

Despite better-than-expected second-quarter results, SunTrust Banks said that it won't request regulatory approval for a dividend increase until next year.

Can Gap Dethrone Lululemon as Queen of Fitness Chic?

Wherever Lululemon goes Gap's Athleta stores follow, as they fight for a share of the women's active apparel market. Here's how their stocks compare.

GE Is Back to Firing on (Most) Cylinders

Despite tough times, the giant conglomerate is growing stronger amazingly well. Here's more on why GE looks like a good long-term bet.

GE Cites Lost Business, Pension Hikes for Mixed Q2

General Electric's lower second-quarter earnings slightly beat expectations, while improved revenues fell short.